Lamivudine: all 230 studies that test it

Page 2 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot StudyCompletedNCT02211482Phase 4
• Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected SubjectsCompletedNCT02202473Phase 4
• Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected SubjectCompletedNCT02159599Phase 4
• Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)CompletedNCT02067767Phase 2
• Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHLStatus unknownNCT01914744Phase 2
• A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)CompletedNCT01900106Phase 3
• Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA ReplicationStatus unknownNCT01894269Phase 4
• Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
• Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01788371Phase 4
• Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited SettingCompletedNCT01772940Phase 4
• Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis BCompletedNCT01743079Phase 4
• Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
• Atazanavir/r + Lamivudine Dual TherapyCompletedNCT01599364Phase 4
• The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
• Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)CompletedNCT01546116Phase 4
• Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in LymphomaWithdrawnNCT01528865Phase 1/2
• Perinatal Antiretroviral Intensification for PMTCT of HIV in Late ComersCompletedNCT01511237Phase 3
• Bioequivalence Study of Pediatric Formulations to Treat HIV InfectionStatus unknownNCT01469520Phase 1
• A Study Evaluating the Efficacy of Glucocorticoids in Patients With Pre-ACLF-HBVStatus unknownNCT01344174Not applicable
• Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected PatientsStatus unknownNCT01318096Not applicable
• Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in AfricaCompletedNCT01088516Phase 4
• Efficacy Optimizing Research of Lamivudine TherapyCompletedNCT01088009Phase 4
• Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected PatientsCompletedNCT01059422Phase 4
• Appropriate Timing of HAART in Co-infected HIV/TB PatientsTerminatedNCT01014481Phase 4
• Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadCompletedNCT01013272Not applicable
• Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With TelbivudineTerminatedNCT01005238Phase 4
• Pharmacokinetics of Lamivudine at Two Different DosesCompletedNCT00985647Phase 1/2
• CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesCompletedNCT00966160Phase 3
• A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in ZimbabweCompletedNCT00834457Phase 2/3
• Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionStatus unknownNCT00810524Phase 4
• Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B PatientsTerminatedNCT00798460Phase 4
• Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected SubjectsStatus unknownNCT00740064Phase 4
• Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTCompletedNCT00719602Early Phase 1
• Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandCompletedNCT00672412Phase 1/2
• A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVPCompletedNCT00669487Phase 3
• Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation CohortCompletedNCT00618176Phase 4
• Comparison of Epzicom and Truvada for the Initial Once Daily HIV TreatmentCompletedNCT00544128Phase 4
• A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B CarriersCompletedNCT00516945Not applicable
• A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic ChemotherapyStatus unknownNCT00489151Not applicable
• Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator ProductsCompletedNCT00455585Phase 4
• HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXTCompletedNCT00380770Phase 4
• A Randomized Controlled Trial of Lamivudine in Acute Hepatitis BCompletedNCT00380614Phase 4
• A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneCompletedNCT00354653Phase 4
• Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TCCompletedNCT00338390Phase 3
• Pharmacokinetic Study Of EPZICOM TabletCompletedNCT00337922Phase 4
• To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and TenofovirCompletedNCT00335192Phase 4
• Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis TreatmentStatus unknownNCT00332306Phase 3
• Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once DailyCompletedNCT00314626Phase 3
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedNCT00312091Phase 1/2
• Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised TrialCompletedNCT00272480Phase 2/3
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIVCompletedNCT00256828Phase 4
• Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve PatientsCompletedNCT00234923Phase 3
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
• Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALTCompletedNCT00230477Phase 4
• Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
• Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.CompletedNCT00158821Phase 3
• The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral RegimensCompletedNCT00152061Not applicable
• A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)CompletedNCT00144183Phase 3
• Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVCompletedNCT00144157Phase 4
• 3TC or No 3TC for HIV With 3TC ResistanceSuspendedNCT00143728Phase 4
• NRTI-Sparing Pilot StudyCompletedNCT00143689Phase 4
• Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
• Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily RegimenCompletedNCT00135369Phase 3
• Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
• Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
• An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
• Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)CompletedNCT00122538Phase 2
• Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in HaitiCompletedNCT00120510Not applicable
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)CompletedNCT00116298Phase 3
• DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral TherapyCompletedNCT00116116Phase 4
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, ChinaCompletedNCT00100594Not applicable
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in SenegalCompletedNCT00100568Not applicable
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
• KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable
• A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced PatientsCompletedNCT00046176Phase 3
• Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected SubjectsCompletedNCT00043953Phase 2
• Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected PatientsCompletedNCT00038220Phase 2
• Zidovudine and Lamivudine Given Once Versus Twice DailyCompletedNCT00014014Phase 1
• A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-LamivudineCompletedNCT00013897Phase 3
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsStatus unknownNCT00011895Phase 4
• Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsStatus unknownNCT00009061Phase 3
• Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected PatientsCompletedNCT00006617Not applicable
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVCompletedNCT00006441Not applicable
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00005106Phase 4
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected PatientsSuspendedNCT00004999Phase 2
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)Status unknownNCT00004981Phase 3
• Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV DrugsCompletedNCT00004852Phase 2
• A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected AdultsCompletedNCT00004585Phase 4
• A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug TherapyCompletedNCT00004583Phase 3
• Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV DrugsStatus unknownNCT00002451Phase 2
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV DrugsCompletedNCT00002442Phase 2
• The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZTCompletedNCT00002436Phase 3
• A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and LamivudineSuspendedNCT00002424Phase 2
• Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug CombinationCompletedNCT00002416Phase 3
• A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002410Phase 3
• The Effect of Teaching HIV-Infected Patients About HIV and TreatmentCompletedNCT00002409Phase 3
• A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002401Not applicable
• A Study of Two Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002400Not applicable
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 DrugsCompletedNCT00002391Phase 3

← Lamivudine overview